Sabby Management, LLC Kiromic Biopharma, Inc. Transaction History

Sabby Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.16 - $11.77 $87,991 - $6.47 Million	549,944 New	549,944 $98,000
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.87 $27,757 - $92,879	-106,758 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$0.6 - $1.82 $310,945 - $943,200	-518,242 Reduced 82.92%	106,758 $91,000
Q4 2021 Feb 14, 2022	BUY	$1.53 - $3.12 $224,723 - $458,259	146,878 Added 30.72%	625,000 $956,000
Q3 2021 Nov 15, 2021	SELL	$2.69 - $4.94 $60,218 - $110,586	-22,386 Reduced 4.47%	478,122 $1.47 Million
Q2 2021 Aug 16, 2021	BUY	$4.81 - $10.34 $2.41 Million - $5.18 Million	500,508 New	500,508 $2.41 Million

107K

Ticker KRBP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,843,200
Market Cap $16M
Description
Kiromic BioPharma, Inc., an artificial intelligence driven allogeneic cell therapy company, engages in developing the multi-indication allogeneic T cell therapies that exploits the natural potency of the Gamma Delta T cell to target solid tumors. The company develops ALEXIS-ISO-1, an allogenic gamma delta CAR-T cell therapy product candidate tar...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.